Leadership in Advocacy Development (LEAD) Program

New for 2023, the American Headache Society announces the Leadership in Advocacy Development (LEAD) Program, which aims to provide training, tools, mentorship, and support for mid-career healthcare professionals and physician advocacy leaders in headache medicine.

Participants will explore new opportunities for professional development through formal didactic sessions and small group workshops with leaders in the field on topics including practice management, advocacy, and project management, as well as the development of an advocacy project over a 2-year longitudinal timeframe.

Health and Safety Policy

The AHS actively monitors the health and safety guidance from the Centers for Disease Control as well as state and local health departments. We want attendees to enjoy a safe environment at all AHS meetings. While the AHS continues to recommend people are up to date on COVID-19 vaccination, attendees of AHS meetings are not required to be vaccinated or verify vaccination status. In addition, masks are optional for AHS meetings and prior antigen testing is not required. We will continue to follow best practices recommended by the Centers for Disease Control and Prevention and abide by any legal mandates and recommendations from government officials in the location of any AHS meeting. These protocols and information are subject to change.

Please note, even with safeguards and the AHS’s overarching commitment to attendee wellness, there remains a risk of contracting COVID-19.